Abstract

Post-mortem tissues samples are a key resource for investigating patterns of gene expression. However, the processes triggered by death and the post-mortem interval (PMI) can significantly alter physiologically normal RNA levels. We investigate the impact of PMI on gene expression using data from multiple tissues of post-mortem donors obtained from the GTEx project. We find that many genes change expression over relatively short PMIs in a tissue-specific manner, but this potentially confounding effect in a biological analysis can be minimized by taking into account appropriate covariates. By comparing ante- and post-mortem blood samples, we identify the cascade of transcriptional events triggered by death of the organism. These events do not appear to simply reflect stochastic variation resulting from mRNA degradation, but active and ongoing regulation of transcription. Finally, we develop a model to predict the time since death from the analysis of the transcriptome of a few readily accessible tissues.

Details

Title
The effects of death and post-mortem cold ischemia on human tissue transcriptomes
Author
Ferreira, Pedro G 1   VIAFID ORCID Logo  ; Muñoz-Aguirre, Manuel 2 ; Reverter, Ferran 3 ; Sá Godinho, Caio P 4 ; Sousa, Abel 5 ; Amadoz, Alicia 6 ; Sodaei, Reza 7 ; Hidalgo, Marta R 8 ; Pervouchine, Dmitri 9 ; Carbonell-Caballero, Jose 10 ; Nurtdinov, Ramil 7 ; Breschi, Alessandra 7 ; Amador, Raziel 7 ; Oliveira, Patrícia 1 ; Çubuk, Cankut 8   VIAFID ORCID Logo  ; Curado, João 7 ; Aguet, François 11   VIAFID ORCID Logo  ; Oliveira, Carla 1 ; Dopazo, Joaquin 12   VIAFID ORCID Logo  ; Sammeth, Michael 4   VIAFID ORCID Logo  ; Ardlie, Kristin G 11 ; Guigó, Roderic 7 

 Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal 
 Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain; Institut Hospital del Mar d’Investigacions Mediques (IMIM), Barcelona, Catalonia, Spain; Departament d’Estadística i Investigació Operativa, Universitat Politècnica de Catalunya, Barcelona, Catalonia, Spain 
 Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain; Institut Hospital del Mar d’Investigacions Mediques (IMIM), Barcelona, Catalonia, Spain; Universitat de Barcelona, Barcelona, Catalonia, Spain 
 Institute of Biophysics Carlos Chagas Filho (IBCCF), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil 
 Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK 
 Department of Bioinformatics, Igenomix S.A, Valencia, Spain 
 Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain; Institut Hospital del Mar d’Investigacions Mediques (IMIM), Barcelona, Catalonia, Spain 
 Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocio, Sevilla, Spain 
 Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain; Institut Hospital del Mar d’Investigacions Mediques (IMIM), Barcelona, Catalonia, Spain; Skolkovo Institute of Science and Technology, Skolkovo, Moscow Region, Russia 
10  Chromatin and Gene expression Lab, Gene Regulation, Stem Cells and Cancer Program, Centre de Regulació Genòmica (CRG), The Barcelona Institute of Science and Technology, PRBB, Barcelona, Spain 
11  The Broad Institute of MIT and Harvard, Cambridge, MA, USA 
12  Department of Bioinformatics, Igenomix S.A, Valencia, Spain; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocio, Sevilla, Spain; Functional Genomics Node (INB), FPS, Hospital Virgen del Rocio, Sevilla, Spain; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Sevilla, Spain 
Pages
1-15
Publication year
2018
Publication date
Feb 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2001897575
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.